Year |
Citation |
Score |
2023 |
Chen CL, Hernandez JC, Uthaya Kumar DB, Machida T, Tahara SM, El-Khoueiry A, Li M, Punj V, Swaminathan SK, Kirtane A, Chen Y, Panyam J, Machida K. Profiling of Circulating Tumor Cells for Screening of Selective Inhibitors of Tumor-Initiating Stem-Like Cells. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2206812. PMID 36949364 DOI: 10.1002/advs.202206812 |
0.713 |
|
2023 |
Prabha S, Merali C, Sehgal D, Nicolas E, Bhaskar N, Flores M, Bhatnagar S, Nethi SK, Barrero CA, Merali S, Panyam J. Incorporation of paclitaxel in mesenchymal stem cells using nanoengineering upregulates antioxidant response, CXCR4 expression and enhances tumor homing. Materials Today. Bio. 19: 100567. PMID 36747581 DOI: 10.1016/j.mtbio.2023.100567 |
0.6 |
|
2022 |
Bhatnagar S, Revuri V, Shah M, Larson P, Shao Z, Yu D, Prabha S, Griffith TS, Ferguson D, Panyam J. Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy. Cancers. 14. PMID 36551577 DOI: 10.3390/cancers14246091 |
0.675 |
|
2021 |
Oseni BA, Azubuike CP, Okubanjo OO, Igwilo CI, Panyam J. Encapsulation of Andrographolide in poly(lactide-co-glycolide) Nanoparticles: Formulation Optimization and Efficacy Studies. Frontiers in Bioengineering and Biotechnology. 9: 639409. PMID 33681172 DOI: 10.3389/fbioe.2021.639409 |
0.412 |
|
2020 |
Cao J, Bhatnagar S, Wang J, Qi X, Prabha S, Panyam J. Cancer stem cells and strategies for targeted drug delivery. Drug Delivery and Translational Research. PMID 33095384 DOI: 10.1007/s13346-020-00863-9 |
0.618 |
|
2020 |
Kim H, Khanna V, Kucaba TA, Zhang W, Sehgal D, Ferguson DM, Griffith TS, Panyam J. TLR7/8 Agonist Loaded Nanoparticles Augment NK Cell-mediated Antibody-based Cancer Immunotherapy. Molecular Pharmaceutics. PMID 32383885 DOI: 10.1021/Acs.Molpharmaceut.0C00271 |
0.4 |
|
2020 |
Ganaie AA, Siddique HR, Sheikh IA, Parray A, Wang L, Panyam J, Villalta PW, Deng Y, Konety BR, Saleem M. A novel terpenoid class for prevention and treatment of KRAS-driven cancers: Comprehensive analysis using in situ, in vitro, and in vivo model systems. Molecular Carcinogenesis. PMID 32291806 DOI: 10.1002/Mc.23200 |
0.349 |
|
2019 |
Kalscheuer S, Khanna V, Kim H, Li S, Sachdev D, DeCarlo A, Yang D, Panyam J. Discovery of HSPG2 (Perlecan) as a Therapeutic Target in Triple Negative Breast Cancer. Scientific Reports. 9: 12492. PMID 31462656 DOI: 10.1038/S41598-019-48993-6 |
0.374 |
|
2019 |
Khanna V, Kalscheuer S, Kirtane A, Zhang W, Panyam J. Perlecan-targeted nanoparticles for drug delivery to triple-negative breast cancer. Future Drug Discovery. 1: FDD8. PMID 31448368 DOI: 10.4155/fdd-2019-0005 |
0.728 |
|
2019 |
Liu G, Khanna V, Kirtane A, Grill A, Panyam J. Chemopreventive efficacy of oral curcumin: a prodrug hypothesis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201900166R. PMID 31136203 DOI: 10.1096/Fj.201900166R |
0.697 |
|
2019 |
Moku G, Layek B, Trautman L, Putnam S, Panyam J, Prabha S. Improving Payload Capacity and Anti-Tumor Efficacy of Mesenchymal Stem Cells Using TAT Peptide Functionalized Polymeric Nanoparticles. Cancers. 11. PMID 30959908 DOI: 10.3390/Cancers11040491 |
0.715 |
|
2019 |
Kim H, Khanna V, Kucaba TA, Zhang W, Ferguson DM, Griffith TS, Panyam J. Combination of sunitinib and PD-L1 blockade enhances anticancer efficacy of TLR7/8 agonist-based nanovaccine. Molecular Pharmaceutics. PMID 30620878 DOI: 10.1021/Acs.Molpharmaceut.8B01165 |
0.354 |
|
2019 |
Kim H, Griffith T, Panyam J. poly(D,L-lactide-co-glycolide) nanoparticles as a vaccine delivery platform for TLR7/8 agonist-based cancer vaccine. The Journal of Pharmacology and Experimental Therapeutics. PMID 30610006 DOI: 10.1124/Jpet.118.254953 |
0.465 |
|
2019 |
Prabha S, Moku G, Layek B, Panyam J. Abstract 3623: Mesenchymal stem cells engineered with TAT peptide functionalized nanoparticles improve therapeutic efficacy of paclitaxel in an orthotopic lung tumor model Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-3623 |
0.647 |
|
2019 |
Layek B, Sehgal D, Panyam J, Prabha S. Abstract 987: Glycoengineered MSCs for targeting platinum resistant ovarian tumors Cancer Research. 79: 987-987. DOI: 10.1158/1538-7445.Am2019-987 |
0.693 |
|
2019 |
Khanna V, Kim H, Zhang W, Larson P, Ferguson D, Panyam J. Abstract 4129: Novel small molecule TLR7/8 agonists for enhancing NK cell-mediated ADCC Cancer Research. 79: 4129-4129. DOI: 10.1158/1538-7445.Am2019-4129 |
0.336 |
|
2019 |
Nethi SK, Sehgal D, Cheng S, Panyam J, Prabha S. Abstract 2175: Synthetic antigen receptor mesenchymal stem cells (SAR-MSCs) targeting perlecan for drug delivery to ovarian cancer Cancer Research. 79: 2175-2175. DOI: 10.1158/1538-7445.Am2019-2175 |
0.643 |
|
2019 |
Sehgal DN, Kalscheuer S, Panyam J. Abstract 2167: Antibody glycoengineering for drug delivery applications Cancer Research. 79: 2167-2167. DOI: 10.1158/1538-7445.Am2019-2167 |
0.366 |
|
2019 |
Layek B, Sehgal D, Argenta PA, Panyam J, Prabha S. Nanoengineering of Mesenchymal Stem Cells via Surface Modification for Efficient Cancer Therapy Advanced Therapeutics. 2: 1900043. DOI: 10.1002/ADTP.201900043 |
0.523 |
|
2018 |
Niu L, Chu LY, Burton SA, Hansen KJ, Panyam J. Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30572036 DOI: 10.1016/J.Jconrel.2018.12.026 |
0.395 |
|
2018 |
Kim H, Sehgal D, Kucaba TA, Ferguson DM, Griffith TS, Panyam J. Acidic pH-responsive polymer nanoparticles as a TLR7/8 agonist delivery platform for cancer immunotherapy. Nanoscale. PMID 30403212 DOI: 10.1039/C8Nr07201A |
0.426 |
|
2018 |
Layek B, Sadhukha T, Panyam J, Prabha S. Nano-engineered mesenchymal stem cells increase therapeutic efficacy of anticancer drug through true active tumor targeting. Molecular Cancer Therapeutics. PMID 29592881 DOI: 10.1158/1535-7163.Mct-17-0682 |
0.696 |
|
2018 |
Kim H, Niu L, Larson P, Kucaba TA, Murphy KA, James BR, Ferguson DM, Griffith TS, Panyam J. Polymeric nanoparticles encapsulating novel TLR7/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy. Biomaterials. 164: 38-53. PMID 29482062 DOI: 10.1016/J.Biomaterials.2018.02.034 |
0.459 |
|
2018 |
Kim H, Larson P, Kucaba TA, Murphy KA, Ferguson DM, Griffith TS, Panyam J. Abstract 718: Nanoparticle-based tumor cell lysate vaccine for cancer immunotherapy Cancer Research. 78: 718-718. DOI: 10.1158/1538-7445.Am2018-718 |
0.415 |
|
2018 |
Layek B, Panyam J, Prabha S. Abstract 3723: Nanoengineered mesenchymal stem cells successfully inhibit tumor progression in a syngeneic mouse model Cancer Research. 78: 3723-3723. DOI: 10.1158/1538-7445.Am2018-3723 |
0.71 |
|
2018 |
Khanna V, Kalscheuer S, Panyam J, Yang D, Li S. Abstract 2897: Therapeutic efficacy of antibodies targeting domain 1 of HSPG2 in breast cancer Cancer Research. 78: 2897-2897. DOI: 10.1158/1538-7445.Am2018-2897 |
0.361 |
|
2017 |
Yhee JY, Yoon HY, Kim H, Jeon S, Hergert P, Im J, Panyam J, Kim K, Nho RS. The effects of collagen-rich extracellular matrix on the intracellular delivery of glycol chitosan nanoparticles in human lung fibroblasts. International Journal of Nanomedicine. 12: 6089-6105. PMID 28860768 DOI: 10.2147/Ijn.S138129 |
0.392 |
|
2017 |
Song JM, Molla K, Anandharaj A, Cornax I, O Sullivan MG, Kirtane AR, Panyam J, Kassie F. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling. Oncotarget. 8: 26927-26940. PMID 28460475 DOI: 10.18632/Oncotarget.15879 |
0.682 |
|
2017 |
Grill AE, Shahani K, Koniar B, Panyam J. Chemopreventive efficacy of curcumin-loaded PLGA microparticles in a transgenic mouse model of HER-2-positive breast cancer. Drug Delivery and Translational Research. PMID 28417445 DOI: 10.1007/S13346-017-0377-4 |
0.42 |
|
2017 |
Kirtane AR, Rothenberger MK, Frieberg A, Nephew K, Schultz-Darken N, Schmidt T, Reimann T, Schlievert P, Haase AT, Panyam J. Evaluation of vaginal drug levels and safety of a locally administered glycerol monolaurate cream in rhesus macaques. Journal of Pharmaceutical Sciences. PMID 28389267 DOI: 10.1016/J.Xphs.2017.03.030 |
0.69 |
|
2017 |
Schmohl JU, Felices M, Oh F, Lenvik AJ, Lebeau AM, Panyam J, Miller JS, Vallera DA. Engineering of Anti-CD133 Tri-Specific Molecule Capable of Inducing NK Expansion and Driving Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC). Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 28231426 DOI: 10.4143/Crt.2016.491 |
0.344 |
|
2017 |
Kirtane AR, Sadhukha T, Kim H, Khanna V, Koniar B, Panyam J. Fibrinolytic enzyme co-therapy improves tumor perfusion and therapeutic efficacy of anticancer nanomedicine. Cancer Research. PMID 28108516 DOI: 10.1158/0008-5472.Can-16-1646 |
0.73 |
|
2017 |
Niu L, Panyam J. Freeze Concentration-Induced PLGA and Polystyrene Nanoparticle Aggregation: Imaging and Rational Design of Lyoprotection. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 28093299 DOI: 10.1016/J.Jconrel.2017.01.019 |
0.311 |
|
2017 |
Sehgal D, Kalscheuer S, Sadhukha T, Panyam J. Abstract 4593: Glycoengineered antibodies for click chemistry applications Cancer Research. 77: 4593-4593. DOI: 10.1158/1538-7445.Am2017-4593 |
0.371 |
|
2017 |
Khanna V, Kalscheuer S, Kirtane A, Panyam J. Abstract 2181: Antibody-conjugated nanoparticles for targeting metastatic triple-negative breast cancer Cancer Research. 77: 2181-2181. DOI: 10.1158/1538-7445.Am2017-2181 |
0.761 |
|
2017 |
Ganaie AA, Siddique HR, Sheikh I, Wang L, Parray A, panyam J, Villalta P, Liao J, deng Y, saleem M. Abstract 1246: Development of a novel KRAS-targeting agent: systematic validation usingin silico, in solution, cell models, PDX and transgenic mouse models Cancer Research. 77: 1246-1246. DOI: 10.1158/1538-7445.Am2017-1246 |
0.338 |
|
2016 |
Siegel RA, Kirtane AR, Panyam J. Assessing the benefits of targeted drug delivery by nanocarriers: A partico/pharmacokinetic framework. Ieee Transactions On Bio-Medical Engineering. PMID 27913319 DOI: 10.1109/Tbme.2016.2632733 |
0.719 |
|
2016 |
Song JM, Anandharaj A, Upadhyaya P, Kirtane AR, Kim JH, Hong KH, Panyam J, Kassie F. Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors. Oncotarget. PMID 27458163 DOI: 10.18632/Oncotarget.10759 |
0.682 |
|
2016 |
Chen C, Swaminathan S, Kirtane A, Panyam J, Machida K. Abstract 4657: Selective inhibitors epigenetically modify and eradicate tumor-initiating stem-like cells through downregulating microRNA 22-mediated TET induction and apoptosis Cancer Research. 76: 4657-4657. DOI: 10.1158/1538-7445.Am2016-4657 |
0.734 |
|
2016 |
Kim H, Niu L, Larson P, Murphy K, Kucaba T, Ferguson D, Griffith T, Panyam J. Abstract 2348: Nanovaccine : A novel immunotherapeutic strategy to treat bladder cancer Cancer Research. 76: 2348-2348. DOI: 10.1158/1538-7445.Am2016-2348 |
0.408 |
|
2016 |
Kirtane AR, Narayan P, Liu G, Panyam J. Polymer-surfactant nanoparticles for improving oral bioavailability of doxorubicin Journal of Pharmaceutical Investigation. 47: 65-73. DOI: 10.1007/S40005-016-0293-5 |
0.745 |
|
2015 |
Han J, Michel AR, Lee HS, Kalscheuer S, Wohl A, Hoye TR, McCormick AV, Panyam J, Macosko CW. Nanoparticles Containing High Loads of Paclitaxel-Silicate Prodrugs: Formulation, Drug Release, and Anticancer Efficacy. Molecular Pharmaceutics. PMID 26505116 DOI: 10.1021/Acs.Molpharmaceut.5B00530 |
0.482 |
|
2015 |
Kirtane AR, Wong HL, Guru BR, Lis LG, Georg GI, Gurvich VJ, Panyam J. Reformulating tylocrebrine in EGFR targeted polymeric nanoparticles improves its therapeutic index. Molecular Pharmaceutics. PMID 26065924 DOI: 10.1021/Acs.Molpharmaceut.5B00173 |
0.781 |
|
2015 |
Kirtane AR, Siegel RA, Panyam J. A pharmacokinetic model for quantifying the effect of vascular permeability on the choice of drug carrier: a framework for personalized nanomedicine. Journal of Pharmaceutical Sciences. 104: 1174-86. PMID 25583443 DOI: 10.1002/Jps.24302 |
0.73 |
|
2015 |
Niu L, Chu L, Hansen K, Panyam J. Abstract A51: Intradermal delivery of polymeric nanoparticle based vaccine formulation using a hollow microneedle system Cancer Immunology Research. 3. DOI: 10.1158/2326-6074.Tumimm14-A51 |
0.375 |
|
2015 |
Kalscheuer S, Panyam J. Abstract 368: Phage display derived antibodies for the detection of mesenchymal CTCs in TNBC Cancer Research. 75: 368-368. DOI: 10.1158/1538-7445.Am2015-368 |
0.322 |
|
2014 |
Grill AE, Koniar B, Panyam J. Co-delivery of natural metabolic inhibitors in a self-microemulsifying drug delivery system for improved oral bioavailability of curcumin. Drug Delivery and Translational Research. 4: 344-52. PMID 25422796 DOI: 10.1007/S13346-014-0199-6 |
0.382 |
|
2014 |
Song JM, Kirtane AR, Upadhyaya P, Qian X, Balbo S, Teferi F, Panyam J, Kassie F. Intranasal delivery of liposomal indole-3-carbinol improves its pulmonary bioavailability. International Journal of Pharmaceutics. 477: 96-101. PMID 25311179 DOI: 10.1016/J.Ijpharm.2014.10.018 |
0.686 |
|
2014 |
Usacheva M, Swaminathan SK, Kirtane AR, Panyam J. Enhanced photodynamic therapy and effective elimination of cancer stem cells using surfactant-polymer nanoparticles. Molecular Pharmaceutics. 11: 3186-95. PMID 25061685 DOI: 10.1021/Mp5003619 |
0.721 |
|
2014 |
Arora S, Swaminathan SK, Kirtane A, Srivastava SK, Bhardwaj A, Singh S, Panyam J, Singh AP. Synthesis, characterization, and evaluation of poly (D,L-lactide-co-glycolide)-based nanoformulation of miRNA-150: potential implications for pancreatic cancer therapy. International Journal of Nanomedicine. 9: 2933-42. PMID 24971005 DOI: 10.2147/Ijn.S61949 |
0.683 |
|
2014 |
Sadhukha T, Wiedmann TS, Panyam J. Enhancing therapeutic efficacy through designed aggregation of nanoparticles. Biomaterials. 35: 7860-9. PMID 24947232 DOI: 10.1016/J.Biomaterials.2014.05.085 |
0.418 |
|
2014 |
Wohl AR, Michel AR, Kalscheuer S, Macosko CW, Panyam J, Hoye TR. Silicate esters of paclitaxel and docetaxel: synthesis, hydrophobicity, hydrolytic stability, cytotoxicity, and prodrug potential. Journal of Medicinal Chemistry. 57: 2368-79. PMID 24564494 DOI: 10.1021/Jm401708F |
0.383 |
|
2014 |
Kirtane AR, Wiedmann T, Panyam J. Abstract 4466: Surface-functionalized nanoparticles for inhalation delivery of chemotherapeutics to lung cancer Cancer Research. 74: 4466-4466. DOI: 10.1158/1538-7445.Am2014-4466 |
0.746 |
|
2014 |
Arora S, Swaminathan SK, Srivastava SK, Singh S, Panyam J, Singh AP. Abstract 1457: Development of miRNA-loaded polymeric nanoformulation for pancreatic cancer therapy Cancer Research. 74: 1457-1457. DOI: 10.1158/1538-7445.Am2014-1457 |
0.319 |
|
2013 |
Ohlfest JR, Zellmer DM, Panyam J, Swaminathan SK, Oh S, Waldron NN, Toma S, Vallera DA. Immunotoxin targeting CD133(+) breast carcinoma cells. Drug Delivery and Translational Research. 3: 195-204. PMID 25787984 DOI: 10.1007/S13346-012-0066-2 |
0.383 |
|
2013 |
Kirtane AR, Panyam J. Polymer nanoparticles: Weighing up gene delivery. Nature Nanotechnology. 8: 805-6. PMID 24202534 DOI: 10.1038/Nnano.2013.234 |
0.727 |
|
2013 |
Pustulka KM, Wohl AR, Lee HS, Michel AR, Han J, Hoye TR, McCormick AV, Panyam J, Macosko CW. Flash nanoprecipitation: particle structure and stability. Molecular Pharmaceutics. 10: 4367-77. PMID 24053447 DOI: 10.1021/Mp400337F |
0.387 |
|
2013 |
Kirtane AR, Kalscheuer SM, Panyam J. Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities. Advanced Drug Delivery Reviews. 65: 1731-47. PMID 24036273 DOI: 10.1016/J.Addr.2013.09.001 |
0.752 |
|
2013 |
Swaminathan SK, Roger E, Toti U, Niu L, Ohlfest JR, Panyam J. CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. 171: 280-7. PMID 23871962 DOI: 10.1016/J.Jconrel.2013.07.014 |
0.503 |
|
2013 |
Sadhukha T, Wiedmann TS, Panyam J. Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy. Biomaterials. 34: 5163-71. PMID 23591395 DOI: 10.1016/J.Biomaterials.2013.03.061 |
0.456 |
|
2013 |
Sadhukha T, Niu L, Wiedmann TS, Panyam J. Effective elimination of cancer stem cells by magnetic hyperthermia. Molecular Pharmaceutics. 10: 1432-41. PMID 23432410 DOI: 10.1021/Mp400015B |
0.4 |
|
2012 |
Wiedmann TS, Sadhukha T, Hammer BE, Panyam J. Image-guided drug delivery in lung cancer. Drug Delivery and Translational Research. 2: 31-44. PMID 25786598 DOI: 10.1007/S13346-011-0053-Z |
0.373 |
|
2012 |
Arora S, Singh S, Piazza GA, Contreras CM, Panyam J, Singh AP. Honokiol: A novel natural agent for cancer prevention and therapy Current Molecular Medicine. 12: 1244-1252. PMID 22834827 DOI: 10.2174/156652412803833508 |
0.32 |
|
2012 |
Pantazis P, Dimas K, Wyche JH, Anant S, Houchen CW, Panyam J, Ramanujam RP. Preparation of siRNA-encapsulated PLGA nanoparticles for sustained release of siRNA and evaluation of encapsulation efficiency. Methods in Molecular Biology (Clifton, N.J.). 906: 311-9. PMID 22791444 DOI: 10.1007/978-1-61779-953-2_25 |
0.446 |
|
2012 |
Roger E, Kalscheuer S, Kirtane A, Guru BR, Grill AE, Whittum-Hudson J, Panyam J. Folic acid functionalized nanoparticles for enhanced oral drug delivery. Molecular Pharmaceutics. 9: 2103-10. PMID 22670575 DOI: 10.1021/Mp2005388 |
0.758 |
|
2012 |
Grill A, Shahani K, Kalscheuer S, Koniar B, Panyam J. Abstract 602: Chemopreventive efficacy of sustained release curcumin microparticles depends on tumorigenesis stage during initial treatment Cancer Research. 72: 602-602. DOI: 10.1158/1538-7445.Am2012-602 |
0.354 |
|
2012 |
Swaminathan SK, Toti U, Panyam J. Abstract 3362: Tumor initiating cells are sensitive to paclitaxel encapsulated in polymeric nanoparticles Cancer Research. 72: 3362-3362. DOI: 10.1158/1538-7445.Am2012-3362 |
0.482 |
|
2011 |
Sharma B, Ma W, Adjei IM, Panyam J, Dimitrijevic S, Labhasetwar V. Nanoparticle-mediated p53 gene therapy for tumor inhibition. Drug Delivery and Translational Research. 1: 43-52. PMID 22553503 DOI: 10.1007/S13346-010-0008-9 |
0.642 |
|
2011 |
Toti US, Guru BR, Hali M, McPharlin CM, Wykes SM, Panyam J, Whittum-Hudson JA. Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles. Biomaterials. 32: 6606-13. PMID 21652065 DOI: 10.1016/J.Biomaterials.2011.05.038 |
0.455 |
|
2011 |
Shahani K, Panyam J. Highly loaded, sustained-release microparticles of curcumin for chemoprevention. Journal of Pharmaceutical Sciences. 100: 2599-609. PMID 21547911 DOI: 10.1002/Jps.22475 |
0.364 |
|
2011 |
Grill A, Panyam J. Abstract 1856: Sustained release curcumin microparticles delay mammary tumorigenesis in BALB-neuT transgenic mice Cancer Research. 71: 1856-1856. DOI: 10.1158/1538-7445.Am2011-1856 |
0.377 |
|
2010 |
Toti US, Guru BR, Grill AE, Panyam J. Interfacial activity assisted surface functionalization: a novel approach to incorporate maleimide functional groups and cRGD peptide on polymeric nanoparticles for targeted drug delivery. Molecular Pharmaceutics. 7: 1108-17. PMID 20527782 DOI: 10.1021/Mp900284C |
0.482 |
|
2010 |
Shahani K, Swaminathan SK, Freeman D, Blum A, Ma L, Panyam J. Injectable sustained release microparticles of curcumin: a new concept for cancer chemoprevention. Cancer Research. 70: 4443-52. PMID 20460537 DOI: 10.1158/0008-5472.Can-09-4362 |
0.412 |
|
2010 |
Patil YB, Swaminathan SK, Sadhukha T, Ma L, Panyam J. The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance. Biomaterials. 31: 358-65. PMID 19800114 DOI: 10.1016/J.Biomaterials.2009.09.048 |
0.523 |
|
2010 |
Khdair A, Chen D, Patil Y, Ma L, Dou QP, Shekhar MP, Panyam J. Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance. Journal of Controlled Release : Official Journal of the Controlled Release Society. 141: 137-44. PMID 19751777 DOI: 10.1016/J.Jconrel.2009.09.004 |
0.52 |
|
2009 |
Grill AE, Johnston NW, Sadhukha T, Panyam J. A review of select recent patents on novel nanocarriers. Recent Patents On Drug Delivery & Formulation. 3: 137-42. PMID 19519573 DOI: 10.2174/187221109788452276 |
0.359 |
|
2009 |
Patil Y, Sadhukha T, Ma L, Panyam J. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance. Journal of Controlled Release : Official Journal of the Controlled Release Society. 136: 21-9. PMID 19331851 DOI: 10.1016/J.Jconrel.2009.01.021 |
0.543 |
|
2009 |
Patil YB, Toti US, Khdair A, Ma L, Panyam J. Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery. Biomaterials. 30: 859-66. PMID 19019427 DOI: 10.1016/J.Biomaterials.2008.09.056 |
0.49 |
|
2009 |
Patil Y, Panyam J. Polymeric nanoparticles for siRNA delivery and gene silencing. International Journal of Pharmaceutics. 367: 195-203. PMID 18940242 DOI: 10.1016/J.Ijpharm.2008.09.039 |
0.48 |
|
2009 |
Khdair A, Handa H, Mao G, Panyam J. Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance in vitro. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 71: 214-22. PMID 18796331 DOI: 10.1016/J.Ejpb.2008.08.017 |
0.513 |
|
2008 |
Khdair A, Gerard B, Handa H, Mao G, Shekhar MP, Panyam J. Surfactant-polymer nanoparticles enhance the effectiveness of anticancer photodynamic therapy. Molecular Pharmaceutics. 5: 795-807. PMID 18646775 DOI: 10.1021/Mp800026T |
0.524 |
|
2008 |
Wu L, Bharatwaj B, Panyam J, da Rocha SR. Core-shell particles for the dispersion of small polar drugs and biomolecules in hydrofluoroalkane propellants. Pharmaceutical Research. 25: 289-301. PMID 17943419 DOI: 10.1007/S11095-007-9466-2 |
0.345 |
|
2007 |
Chavanpatil MD, Khdair A, Patil Y, Handa H, Mao G, Panyam J. Polymer-surfactant nanoparticles for sustained release of water-soluble drugs. Journal of Pharmaceutical Sciences. 96: 3379-89. PMID 17721942 DOI: 10.1002/Jps.20961 |
0.469 |
|
2007 |
Chavanpatil MD, Khdair A, Gerard B, Bachmeier C, Miller DW, Shekhar MP, Panyam J. Surfactant-polymer nanoparticles overcome P-glycoprotein-mediated drug efflux. Molecular Pharmaceutics. 4: 730-8. PMID 17705442 DOI: 10.1021/Mp070024D |
0.532 |
|
2007 |
Chavanpatil MD, Khdair A, Panyam J. Surfactant-polymer nanoparticles: a novel platform for sustained and enhanced cellular delivery of water-soluble molecules. Pharmaceutical Research. 24: 803-10. PMID 17318416 DOI: 10.1007/S11095-006-9203-2 |
0.506 |
|
2007 |
Shahani K, Jonnalagadda S, Handa H, Mao G, Panyam J. Phospholipid nanoparticles: Process optimization using factorial design and atomic force microscopy Journal of Biomedical Nanotechnology. 3: 394-400. DOI: 10.1166/Jbn.2007.052 |
0.397 |
|
2007 |
Chavanpatil MD, Handa H, Mao G, Panyam J. Incorporation of phospholipids enhances cellular uptake and retention of surfactant-polymer nanoparticles Journal of Biomedical Nanotechnology. 3: 291-296. DOI: 10.1166/Jbn.2007.040 |
0.534 |
|
2006 |
Chavanpatil MD, Khdair A, Panyam J. Nanoparticles for cellular drug delivery: mechanisms and factors influencing delivery. Journal of Nanoscience and Nanotechnology. 6: 2651-63. PMID 17048473 DOI: 10.1166/Jnn.2006.443 |
0.501 |
|
2006 |
Chavanpatil MD, Patil Y, Panyam J. Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux. International Journal of Pharmaceutics. 320: 150-6. PMID 16713148 DOI: 10.1016/J.Ijpharm.2006.03.045 |
0.475 |
|
2004 |
Panyam J, Labhasetwar V. Targeting intracellular targets. Current Drug Delivery. 1: 235-47. PMID 16305387 DOI: 10.2174/1567201043334768 |
0.635 |
|
2004 |
Panyam J, Labhasetwar V. Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles. Molecular Pharmaceutics. 1: 77-84. PMID 15832503 DOI: 10.1021/Mp034002C |
0.688 |
|
2004 |
Panyam J, Williams D, Dash A, Leslie-Pelecky D, Labhasetwar V. Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles. Journal of Pharmaceutical Sciences. 93: 1804-14. PMID 15176068 DOI: 10.1002/Jps.20094 |
0.647 |
|
2004 |
Satturwar PM, Fulzele SV, Panyam J, Mandaogade PM, Mundhada DR, Gogte BB, Labhasetwar V, Dorle AK. Evaluation of new rosin derivatives for pharmaceutical coating. International Journal of Pharmaceutics. 270: 27-36. PMID 14726119 DOI: 10.1016/J.Ijpharm.2003.10.021 |
0.576 |
|
2003 |
Panyam J, Dali MM, Sahoo SK, Ma W, Chakravarthi SS, Amidon GL, Levy RJ, Labhasetwar V. Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles. Journal of Controlled Release : Official Journal of the Controlled Release Society. 92: 173-87. PMID 14499195 DOI: 10.1016/S0168-3659(03)00328-6 |
0.564 |
|
2003 |
Panyam J, Sahoo SK, Prabha S, Bargar T, Labhasetwar V. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles. International Journal of Pharmaceutics. 262: 1-11. PMID 12927382 DOI: 10.1016/S0378-5173(03)00295-3 |
0.74 |
|
2003 |
Panyam J, Labhasetwar V. Dynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharmaceutical Research. 20: 212-20. PMID 12636159 DOI: 10.1023/A:1022219003551 |
0.589 |
|
2003 |
Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Advanced Drug Delivery Reviews. 55: 329-47. PMID 12628320 DOI: 10.1016/S0169-409X(02)00228-4 |
0.684 |
|
2002 |
Panyam J, Lof J, O'Leary E, Labhasetwar V. Efficiency of Dispatch and Infiltrator cardiac infusion catheters in arterial localization of nanoparticles in a porcine coronary model of restenosis. Journal of Drug Targeting. 10: 515-23. PMID 12575742 DOI: 10.1080/1061186021000038391 |
0.588 |
|
2002 |
Prabha S, Zhou WZ, Panyam J, Labhasetwar V. Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. International Journal of Pharmaceutics. 244: 105-15. PMID 12204570 DOI: 10.1016/S0378-5173(02)00315-0 |
0.734 |
|
2002 |
Panyam J, Zhou WZ, Prabha S, Sahoo SK, Labhasetwar V. Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 16: 1217-26. PMID 12153989 DOI: 10.1096/Fj.02-0088Com |
0.751 |
|
2002 |
Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. Journal of Controlled Release : Official Journal of the Controlled Release Society. 82: 105-14. PMID 12106981 DOI: 10.1016/S0168-3659(02)00127-X |
0.738 |
|
1999 |
Panyam J, Kumar V, Mishra B. Recent trends in drug delivery systems: Lymphatic drug targeting and transportation Acta Pharmaceutica Turcica. 41: 131-139. |
0.306 |
|
Show low-probability matches. |